Rivosana, UAB - employees and salaries

Company age: 9 y. 3 mo.

Update

Rivosana - Basic salary and employee information

Number of employees

11

Annual change in number of employees

+11% (+1)

Average salary

1936 €

Change in average wage per year

+51% (+770 €)

Salary compared to sector average

81%

1 936 € vs 2 378 € sect.

Annual employee turnover

Employee turnover rate = (number of employees who left during the year / average annual number of employees) x 100 %

0,0 %

Number of employees

Employee turnover rate

Employee turnover is a term describing the process when employees leave an organization and are replaced by new ones. It is an important human resource management indicator reflecting the quality of the company's work environment, employee satisfaction, and organizational culture.

Employee turnover rate = (number of employees who left during the year / average annual number of employees) x 100 %

Average salary

Overview of company employees and salaries

This description was generated by artificial intelligence for the end of 2025. Report if inaccurate.
Rivosana, UAB (code 304559755) is a Micro company operating in wholesale of pharmaceutical and medical goods. Its workforce has expanded from an average of 5 employees in 2023 to 7 in 2024, 9 in 2025, and 10 so far in 2026. This corresponds to 11.1% year-on-year growth and 42.9% growth over two years, although the small headcount means each additional employee has a noticeable impact on the figures. Average monthly gross wages moved from €2,680.80 in 2023 to €1,874.32 in 2024 and €1,584.52 in 2025, before increasing to €2,228.65 so far in 2026. As a result, pay is 40.6% higher year on year and 18.9% above the level two years earlier. Based on the latest staffing level, the estimated annual payroll is about €267.4K. Productivity indicators are also solid, with revenue per employee at €111.5K and profit per employee at €28.3K.

We can offer mass generation of descriptions and translations using artificial intelligence technologies for your business as well. Read more.